Erdafitinib therapeutic range

Erdafitinib (Erdafitinib) is a targeted therapy drug mainly used to treat patients with fibroblast growth factor receptor (FGFR) gene abnormalities, especially those with advanced or metastatic urothelial cancer. The following is a detailed introduction to the therapeutic scope of erdafitinib:

The main application area of erdafitinib is advanced or metastatic urothelial carcinoma, a cancer that originates in the urinary system, including the bladder, urethra and renal pelvis. In some patients with urothelial cancer, the FGFR gene behaves abnormally, often as a result of gene mutation or activation. This abnormal activation can promote the abnormal growth and spread of tumor cells. Therefore, by targeting the inhibition of FGFR, erdafitinib can intervene in this process and inhibit the growth of cancer cells, thereby providing therapeutic effects.

Clinical trial results show that erdafitinib shows significant efficacy in patients with urothelial cancer with FGFR genetic abnormalities, making it an innovative drug approved by the FDA to treat this specific type of cancer. This targeted therapy approach provides patients with a more personalized and effective treatment option.

However, it is worth noting that erdafitinib is not suitable for all patients with urothelial cancer, but is mainly used for patients whose classic treatment options cannot provide satisfactory results, and genetic testing and other means are needed to determine whether the patient is suitable for this treatment.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.